Ravi Agrawal Revised's Insider Trades & SAST Disclosures
Ravi Agrawal Revised's most recent trade in Ajanta Pharma Ltd. was a Revoke of 190,250 Equity Shares done at an average price of Rs. 1509.9 . Disclosure was reported to the exchange on Sept. 29, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Ravi Agrawal Revised in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ajanta Pharma | Ravi Agrawal, Trustee Ravi Agrawal Trust (Revised) | Promoter | Revoke | 29 Sep 2023 | 190,250 | 16,386,623 (13.01%) | 0.15% | 1509.9 | 287,267,987 | 21 Jun 2023 21 Jun 2023 |
Insider Trading | Equity Shares | Pledge Released |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.